<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01128582</url>
  </required_header>
  <id_info>
    <org_study_id>Rozerem</org_study_id>
    <nct_id>NCT01128582</nct_id>
  </id_info>
  <brief_title>Effect of Rozerem on the Perception of GERD Symptoms in Patients With Chronic Insomnia.</brief_title>
  <acronym>Rozerem</acronym>
  <official_title>Effect of Rozerem on the Perception of Gastroesophageal Reflux Disease (GERD) Symptoms in Patients With Chronic Insomnia.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Southern Arizona VA Health Care System</agency>
      <agency_class>U.S. Fed</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Southern Arizona VA Health Care System</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To determine if administration of Rozerem in comparison to a placebo reduces or eliminates
      gastroesophageal reflux disease(GERD) symptoms in individuals with both GERD and chronic
      insomnia.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a prospective, randomized, double-blind parallel group study comparing the effect of
      Rozerem vs. placebo on gastroesophageal reflux disease(GERD) symptomatology as the primary
      outcome, and sleep quality and quality of life as secondary outcomes.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Active, not recruiting</last_known_status>
  <start_date>March 2009</start_date>
  <completion_date type="Anticipated">December 2011</completion_date>
  <primary_completion_date type="Anticipated">December 2011</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The effect of Rozerem vs. placebo on gastroesophageal reflux disease(GERD) symptomatology.</measure>
    <time_frame>4 week trial</time_frame>
    <description>The effect of Rozerem vs. placebo on GERD symptomatology as the primary outcome, and sleep quality and quality of life as secondary outcomes.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Improving quality of sleep and quality of life.</measure>
    <time_frame>4 week trial period</time_frame>
    <description>It is believed that poor quality of sleep can cause more esophageal acid exposure. Thus, it is possible that treatment of insomnia may have a beneficial effect on GERD symptomatology as well as actually reduce esophageal acid reflux.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Gastroesophageal Reflux Disease</condition>
  <condition>Chronic Insomnia</condition>
  <arm_group>
    <arm_group_label>Rozerem</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Comparing the effect of Rozerem vs. placebo on GERD symptomatology.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Comparing the effect of Rozerem vs. placebo on GERD symptomatology</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Rozerem (ramelteon)</intervention_name>
    <description>dosage= take 1 tablet(8 MG) 20 min. before bedtime</description>
    <arm_group_label>Rozerem</arm_group_label>
    <other_name>Rozerem</other_name>
    <other_name>ramelteon</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>placebo</intervention_name>
    <description>Comparing the effect of Rozerem vs. placebo on GERD symptomatology.</description>
    <arm_group_label>placebo</arm_group_label>
    <other_name>sugar pill</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Stop H2 blockers 72 hrs prior to starting study

          -  Stop PPI - 3 weeks prior to staring study

          -  Heartburn 3+ times a week

          -  Insomnia 3+ times a week for 3 months

          -  Erosive esophagitis or Abnormal pH test

        Exclusion Criteria:

          -  On PPI or H2 blocker &amp; not willing to get off

          -  Normal EGD (upper endoscopy) w/ normal pH test

          -  Upper Endoscopy(EGD)with erosive esophagitis(EE)- (LA C&amp;D) LA=Los Angeles criteria.
             Grades include A-D

          -  Previous gastrointestinal Surgery

          -  HX of Diabetes/neuropathy

          -  HX of seizures

          -  Known psychological abnormalities(depression,anxiety...)

          -  Clinically Significant Underlying co morbidity

          -  Narcotic medications(pain meds)

          -  Regularly taking sleeping medications (2 week wash-out allowed)

          -  Taking medications that alter sleep-Psychotropic's, antihistamines, Narcotics and
             Benzodiazepines Sleep Apnea or other sleep disorders-PLM, RLS etc.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>82 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ronnie Fass, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Southern Arizona Veterans Health Care System-BREFSA</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Southern Arizona Veterans Health Care System</name>
      <address>
        <city>Tucson</city>
        <state>Arizona</state>
        <zip>85723</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 21, 2010</study_first_submitted>
  <study_first_submitted_qc>May 21, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 24, 2010</study_first_posted>
  <last_update_submitted>May 11, 2011</last_update_submitted>
  <last_update_submitted_qc>May 11, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 12, 2011</last_update_posted>
  <responsible_party>
    <name_title>Ronnie Fass MD</name_title>
    <organization>Southern Arizona VA Health Care System</organization>
  </responsible_party>
  <keyword>GERD</keyword>
  <keyword>Insomnia</keyword>
  <keyword>Acid Reflux</keyword>
  <keyword>Heartburn</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sleep Initiation and Maintenance Disorders</mesh_term>
    <mesh_term>Gastroesophageal Reflux</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

